David Coyle, MD
Interventional Cardiology · Boise, IDNPI 1023210515
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,685 of the $2,573 with a category attached, or 65.5%. 10 manufacturers reported payments, led by Edwards Lifesciences at 58.1% of the total. Reporting peaked in 2023 at $1,354 and has fallen 54.1% since, to $621 in 2025. That places this record below the midpoint for interventional cardiology clinicians in ID, where the typical reported total is $3,406.
Across 63 payments — averaging $40.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1K
- Abbott$242
- Boston Scientific$234
- Abiomed$184
- E.r. Squibb & Sons, L.L.C.$123
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$81
- plus $213 from 4 others
What the payments were for
- Travel & lodging$88835%
- Food & beverage$1,68565%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 20 | $1,496 |
| Abbott | 6 | $242 |
| Boston Scientific | 16 | $234 |
| Abiomed | 7 | $184 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $81 |
| Shockwave Medical, Inc | 1 | $80 |
| Amgen | 4 | $65 |
| Chiesi USA, Inc. | 1 | $39 |
| AstraZeneca | 2 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,573 in reported general payments places this provider in the 40th percentile of 29 interventional cardiology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 118 | $155,862 |
| Repatha SureclickEvolocumab | 25 | $20,234 |
| Metoprolol Succinate | 157 | $1,862 |
| Atorvastatin Calcium | 99 | $942 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 45 | $807 |
| Rosuvastatin Calcium | 50 | $717 |
| ClopidogrelClopidogrel Bisulfate | 51 | $554 |
| Amlodipine Besylate | 51 | $462 |
| Lisinopril | 61 | $436 |
| Carvedilol | 39 | $423 |
| Losartan Potassium | 73 | $419 |
| Metoprolol Tartrate | 60 | $384 |
| Warfarin Sodium | 32 | $354 |
| Spironolactone | 40 | $243 |
| Nitroglycerin | 17 | $180 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Boise
- Joseph WalshBoise$115K
- Kara DenbyBoise$18K
- Jeffrey HeslopBoise$17K
- Kendra CoonseBoise$17K
- Patrick ColemanBoise$11K
- Robert DuerrBoise$11K
- Frederick CostelloBoise$5K
- Alex JohnsonBoise$3K
- Mark ParentBoise$2K
- Carl KapadiaBoise$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.